Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.

他のバージョン（1件）を表示する

As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment of an...

書誌詳細
主要な著者:	Latimer, N, Carroll, C, Wong, R, Tappenden, P, Venning, M, Luqmani, R
フォーマット:	Journal article
言語:	English
出版事項:	2014

類似資料

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
著者:: Latimer, N, 等
出版事項: (2014)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
著者:: Guerry, M, 等
出版事項: (2012)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
著者:: Flossmann, O, 等
出版事項: (2006)

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis
著者:: Michael A Paley, 等
出版事項: (2019-01-01)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: Robson, J, 等
出版事項: (2017)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
著者:: Basu, N, 等
出版事項: (2014)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
著者:: Pearce, F, 等
出版事項: (2017)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
著者:: Thomas Hellmark, 等
出版事項: (2019-03-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis following rituximab: Outcomes of 50 patients in a tertiary single centre
著者:: Fahidah Alenzi, 等
出版事項: (2023-09-01)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
著者:: Valentina Binda, 等
出版事項: (2021-12-01)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
著者:: Alan D. Salama
出版事項: (2020-01-01)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: Cheng-Hua Weng, 等
出版事項: (2019-12-01)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
著者:: Robson, J, 等
出版事項: (2017)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
著者:: Saket Jha, 等
出版事項: (2019-01-01)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
著者:: Xinyu Weng, 等
出版事項: (2022-03-01)

Cardiovascular and Cerebrovascular Outcomes in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
著者:: Shiyu Xiao, 等
出版事項: (2024-01-01)

Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: Christopher Maximilian Arends, 等
出版事項: (2020-06-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
著者:: Haiting Wu, 等
出版事項: (2022-04-01)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: Marta Casal Moura, 等
出版事項: (2022-11-01)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
著者:: Daisuke Tsukui, 等
出版事項: (2021-01-01)

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
著者:: Hellmich, B, 等
出版事項: (2007)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
著者:: Laura S. van Dam, 等
出版事項: (2020-12-01)

Use of a computerised system to facilitate evaluation of anti-neutrophil cytoplasm (ANCA Associated) vasculitis (AAV) and other forms of systemic vasculitis
著者:: Luqmani, R, 等
出版事項: (2017)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
著者:: E. N. Vorkel, 等
出版事項: (2024-12-01)

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: Weijun Liu, 等
出版事項: (2024-05-01)

Recent advances in the diagnosis and treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: Si-wei Tang, 等
出版事項: (2024-03-01)

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
著者:: Anders Esberg, 等
出版事項: (2022-08-01)

Late Onset of Rivaroxaban-Associated Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis
著者:: Muskan Agarwal MD, 等
出版事項: (2023-10-01)

A case of Sjögren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: K. Kaynar, 等
出版事項: (2023-07-01)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
著者:: Liye Suo, 等
出版事項: (2019-01-01)

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic antibody associated vasculitis
著者:: Naidan Zhang, MS, 等
出版事項: (2022-06-01)

Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
著者:: Salomon R, 等
出版事項: (2011-09-01)

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
著者:: CM Wortel, 等
出版事項: (2025-02-01)

Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians
著者:: David Massicotte-Azarniouch, 等
出版事項: (2024-08-01)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
著者:: Mukhtyar, C, 等
出版事項: (2006)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
著者:: Zhi-Ying Li, 等
出版事項: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
著者:: Moog P, 等
出版事項: (2015-11-01)

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
著者:: Despina Michailidou, 等
出版事項: (2022-06-01)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
著者:: McLaren, J, 等
出版事項: (2001)

Anti-neutrophil cytoplasmic antibody–associated vasculitis complicated with diffuse alveolar haemorrhage and central nervous system vasculitis
著者:: Takashi Nawata, 等
出版事項: (2021-04-01)